#LCSM Chat Topic 9/8: You’ve Been Diagnosed With Lung Cancer…Now What?
Our topic for the next #LCSM Chat on Thursday, September 8, 2016, at 5 PM Pacific (8 PM Eastern) is “You’ve Been Diagnosed with Lung Cancer…Now What?” Our moderator will be Laronica Conway (@louisianagirl91). Have you (or someone you know) been recently diagnosed with lung cancer? What happens next? Just getting past the shock of the diagnosis can be challenging and emotionally draining, but knowing the next steps can possibly help remove some of the uncertainty. This week we’ll open up the discussion and seek advice from health care providers and from… Read More
#LCSM Chat 5/5: Know Before You Go—Conference Prep 101
Lung cancer patients and advocates are increasingly joining healthcare, pharma, government agency and biotech industry representatives at cancer-related medical conferences such as the American Association for Cancer Research (AACR) Annual Meeting in April and the American Society for Clinical Oncology Annual Meeting in June. Planning ahead for these meetings is essential for getting the most out of your time. The events, which can last several days, often have many sessions happening at the same time in different rooms. In addition to scheduling considerations, the terminology, graphics, and scientific concepts discussed in the… Read More
#LCSM Chat 4/21: Doctor Shopping in the Age of Social Media
The doctor-patient relationship is without a doubt a keystone of medical care. This relationship is arguably most intense in the field of oncology. For patients, few things are as life altering as a cancer diagnosis. This is particularly true for lung cancer, given its poor survival statistics and the social stigma sometimes associated with the disease. Thus, for many lung cancer patients, a surgeon or oncologist (sometimes both) become an incredibly important person for several months, if not years. These doctors will gather the patients’ data, inform them of their diagnoses, administer… Read More
#LCSM 
You must be logged in to post a comment.